Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (17219)	3/11/1998 2:17:00 PM
From: medsunman	Read Replies (4) \| Respond to of 32384

Henry, how about a more detailed response to Bernie's question. Also, for my benefit, could you explain what the relationship is between Lilly/LGND and Evista? Many thanks.

To: Henry Niman who wrote (17219)	3/11/1998 2:41:00 PM
From: dwc	Read Replies (1) \| Respond to of 32384

Henry: Question..is BIO '98 in NYC in June a big deal? Is LGND going to present anything there?

To: Henry Niman who wrote (17219)	3/11/1998 3:56:00 PM
From: Flagrante Delictu	Read Replies (2) \| Respond to of 32384

Henry, >> They SYNERGIZE << Yes, Henry, I know that. I was trying to elicit whether the article on the street .com mentioned LGND's compounds in conjunction with the report that Evista was so great. In other words, did they say that Evista, when used in conjunction with either Panretin or Targretin, would have these exciting results? Or did they say that Evista would, without mentioning LGND's compounds? Sorry for the confusion wrought. Bernie.